Squamous cell carcinoma of the urinary bladder

Area of Science:

• Urology
• Oncology
• Parasitology

Background:

• Squamous cell carcinoma (SCC) of the urinary bladder is a significant health concern, particularly in regions endemic for schistosomiasis.
• Bilharziasis, caused by Schistosoma haematobium, is a known risk factor for bladder cancer.

Purpose of the Study:

• To investigate the clinical characteristics, treatment, and outcomes of patients with squamous cell carcinoma of the urinary bladder.
• To assess the association between urinary bilharziasis and bladder SCC.
• To evaluate the efficacy of radical cystectomy in a specific patient cohort.

Main Methods:

• A retrospective study of 52 patients with bladder SCC over a 6-year period.
• Clinical data, including history of bilharziasis, physical examination findings (sandy patches), and imaging (intravenous urography), were analyzed.
• Treatment modalities included radical radiotherapy and radical cystectomy with urinary diversion.

Main Results:

• Bladder SCC constituted 27% of all bladder tumors studied.
• A high prevalence of urinary bilharziasis (31% history, 69% stigmata) was observed.
• Most tumors occurred in the trigone region, with 60% presenting at advanced stages (T3 NO MO).
• Radical cystectomy in patients under 55 years yielded a 5-year survival rate of 75%.

Conclusions:

• Urinary bilharziasis is strongly associated with squamous cell carcinoma of the urinary bladder.
• Early detection and aggressive treatment, such as radical cystectomy in younger patients, are crucial for improving survival outcomes.
• Further research into prevention and management strategies for bilharzia-associated bladder cancer is warranted.